RUOZI, Barbara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.908
EU - Europa 11.572
AS - Asia 3.672
SA - Sud America 68
AF - Africa 45
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 20
Totale 35.311
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.848
GB - Regno Unito 4.321
IT - Italia 3.308
SE - Svezia 1.238
CN - Cina 1.195
SG - Singapore 923
DE - Germania 717
HK - Hong Kong 625
UA - Ucraina 577
TR - Turchia 575
FI - Finlandia 377
FR - Francia 254
BG - Bulgaria 235
IN - India 94
IE - Irlanda 80
BE - Belgio 78
RO - Romania 71
NL - Olanda 61
RU - Federazione Russa 60
CA - Canada 48
KR - Corea 47
ID - Indonesia 46
LT - Lituania 41
BR - Brasile 37
IR - Iran 35
ES - Italia 33
CH - Svizzera 31
VN - Vietnam 28
AU - Australia 22
JP - Giappone 22
CZ - Repubblica Ceca 18
EG - Egitto 18
MY - Malesia 18
PL - Polonia 17
EU - Europa 16
GR - Grecia 15
IL - Israele 15
PT - Portogallo 13
IQ - Iraq 11
TW - Taiwan 10
HU - Ungheria 9
PK - Pakistan 9
ZA - Sudafrica 9
CL - Cile 8
CO - Colombia 8
SN - Senegal 7
AR - Argentina 6
MX - Messico 6
AT - Austria 4
BZ - Belize 4
DZ - Algeria 4
NZ - Nuova Zelanda 4
PE - Perù 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
EC - Ecuador 3
NO - Norvegia 3
TH - Thailandia 3
YE - Yemen 3
AN - Antille olandesi 2
BY - Bielorussia 2
HR - Croazia 2
LK - Sri Lanka 2
MA - Marocco 2
NG - Nigeria 2
RS - Serbia 2
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CY - Cipro 1
GH - Ghana 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
NP - Nepal 1
PH - Filippine 1
RE - Reunion 1
TZ - Tanzania 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 35.311
Salva come PNG Salva come JPEG
Città #
Southend 3.817
Fairfield 2.347
Chandler 1.756
Woodbridge 1.635
Ashburn 1.462
Santa Clara 1.394
Jacksonville 1.261
Houston 1.057
Seattle 978
Dearborn 953
Ann Arbor 918
Wilmington 912
Cambridge 795
Nyköping 775
Singapore 702
Hong Kong 612
Modena 514
Beijing 387
Izmir 353
Princeton 249
Sofia 230
Eugene 219
San Diego 209
Chicago 206
Milan 171
Helsinki 163
New York 138
Des Moines 117
Rome 117
Redwood City 112
London 100
Bremen 93
Bologna 92
Falls Church 88
Fremont 87
Brussels 71
Dublin 66
Shanghai 60
Reggio Emilia 56
Hefei 52
Munich 51
Florence 49
Boardman 44
Jakarta 43
Como 42
Parma 42
Naples 41
Nanjing 38
Turin 38
Norwalk 37
Tulare 33
Napoli 32
Guangzhou 30
Bari 28
Catania 28
Frankfurt am Main 28
Kunming 26
San Giuliano Milanese 26
Los Angeles 25
Jinan 24
Verona 23
Dong Ket 22
Hounslow 21
Palermo 19
Dallas 18
Ferrara 18
Toronto 18
Kilburn 17
Mountain View 17
Perugia 17
Saint Petersburg 17
Cairo 16
Indiana 16
Kocaeli 16
Padova 16
Phoenix 16
Brescia 15
Washington 15
Wuhan 15
Dongguan 14
Genoa 14
San Mateo 13
Amsterdam 12
Limerick 12
Prescot 12
Sassuolo 12
Sydney 12
Auburn Hills 11
Halifax 11
Lappeenranta 11
Milwaukee 11
Pescara 11
Salerno 11
Bengaluru 10
Brno 10
Carmichael 10
Castelnuovo Di Porto 10
Hangzhou 10
Istanbul 10
Messina 10
Totale 26.598
Salva come PNG Salva come JPEG
Nome #
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 386
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 385
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 302
Novel Curcumin loaded nanoparticles engineered for Blood-Brain Barrier crossing and able to disrupt Abeta aggregates 290
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 272
Protein corona and nanoparticles: How can we investigate on? 256
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 253
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 250
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 246
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 243
Nanoparticle transport across the blood brain barrier 241
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 238
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 237
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 237
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 234
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 232
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 229
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 228
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 228
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 226
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 224
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 222
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 222
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 220
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 219
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 218
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 217
The “fate” of polymeric and lipid nanoparticles for brain delivery and targeting: Strategies and mechanism of blood–brain barrier crossing and trafficking into the central nervous system 214
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 210
Sistema di veicolazione e rilascio di farmaci antiparassitari e loro uso in campo medico 208
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 208
Amphiphilic Erythromycin-Lipoamino Acid Ion Pairs: Characterization and In Vitro Microbiological Evaluation 207
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 207
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 205
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 204
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 204
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 203
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 203
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 201
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 200
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 199
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 198
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 196
Functionalization of liposomes: microscopical methods for preformulative screening 196
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 195
Apoferritin nanocage as drug reservoir: is it a reliable drug delivery system? 195
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 195
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 194
Colloidal systems for CNS drug delivery 193
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 193
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 193
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 193
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 192
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 192
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier 191
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 189
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 189
STUDIO TECNOLOGICO DI OTTIMIZZAZIONE DI SISTEMI NANOPARTICELLARI ALLESTITI IN EMULSIONE SEMPLICE 187
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 187
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter 187
Nanoparticles as Blood–Brain Barrier Permeable CNS Targeted Drug Delivery Systems 185
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 185
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 183
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53wildtype JVM-2 But Not Towards p53mutated BJAB Leukemic Cells 183
Nanosystems based on siRNA silencing HuR expression counteract diabetic retinopathy in rat 183
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 183
Amphiphilic ion pairs of tobramycin with lipoamino acids 181
Studi preformulativi sul complesso di inclusione tra acido ursodesossicolico e beta-ciclodestrine 179
Detection of PLGA-based nanoparticles at single cell level by Synchrotron Radiation FTIR Spectromicroscopy and correlation with X-Ray Fluorescence Microscopy 179
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 179
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 178
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 178
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 177
Preparazione e caratterizzazione del complesso tra acido iodesossicolico e 2-idrossipropil-beta-ciclodestrina 177
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 177
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 176
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 176
Cationic liposomes for gene transfection 175
Polymeric nanoparticles for the drug delivery to the central nervous system 174
Ketorolac tromethamine liposomes: Encapsulation and release studies 172
Brain-targeted polymeric nanoparticles: in vivo evidences after different routes of administration in rodents. 172
Sustained Zero-Order Release of Intact Ultra-Stable Drug-Loaded Liposomes from an Implantable Nanochannel Delivery System 170
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 170
Brain targeting with polymeric nanoparticles: which administration route should we take? 169
Preparation and Microbiological Evaluation of Amphiphilic Kanamycin-Lipoamino Acid Ion-Pairs 168
Application of atomic force microscopy to characterize liposomes as drug and gene carriers 167
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 166
Nanomedicine and neurodegenerative disorders: So close yet so far 166
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 166
Interazione tra liposomi cationici e DNA plasmidico: studi di transfezione genica in diverse linee cellulari 163
Peptide-derivatized biodegradable nanoparticles able to cross the blood brain barrier 162
Nanomedicine: the future for advancing medicine and neuroscience 162
Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier. 162
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 161
Preparation, characterization and photostability assessment of curcumin microencapsulated within methacrylic copolymers 161
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 160
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 160
Evidence of the existence of 2:1 guest-host complexes between diclofenac and cyclodextrins in D2O solutions. A 1H and 13C NMR study on diclofenac/beta-cyclodextrin and diclofenac/2-hydroxypropyl-beta-cyclodextrin systems 159
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 159
The bridge between Nanotechnology and Neuroscience: Neuro-Nanomedicine 158
Totale 20.144
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.397
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.590 0 0 0 0 824 946 1.160 789 868 292 439 272
2020/20215.893 848 233 449 524 492 362 487 701 255 899 365 278
2021/20224.234 189 486 381 289 161 212 238 229 498 332 698 521
2022/20234.919 592 536 401 482 569 711 116 437 578 91 188 218
2023/20243.460 177 202 220 286 732 356 396 426 127 89 148 301
2024/20253.433 526 176 238 820 1.673 0 0 0 0 0 0 0
Totale 35.712